<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2393-6797</journal-id>
<journal-title><![CDATA[Revista Uruguaya de Medicina Interna ]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. Urug. Med. Int.]]></abbrev-journal-title>
<issn>2393-6797</issn>
<publisher>
<publisher-name><![CDATA[Sociedad de Medicina Interna del Uruguay]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2393-67972018000300033</article-id>
<article-id pub-id-type="doi">10.26445/03.01.2</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Paraparesia espástica por HTLV-I: 20 años después. A propósito de un caso]]></article-title>
<article-title xml:lang="en"><![CDATA[Spastic paraparesis by HTLV-I: 20 years later. About a case]]></article-title>
<article-title xml:lang="pt"><![CDATA[Paraparesia espástica pelo HTLV-I: 20 anos depois. Sobre um caso]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sommaruga]]></surname>
<given-names><![CDATA[Nicolás]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Lima]]></surname>
<given-names><![CDATA[Edgar]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Salamano]]></surname>
<given-names><![CDATA[Ronald]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de la República Hospital de Clínicas -&#8220;Dr. Manuel Quintela&#8221; Instituto de Neurología]]></institution>
<addr-line><![CDATA[Montevideo ]]></addr-line>
<country>Uruguay</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>10</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>10</month>
<year>2018</year>
</pub-date>
<volume>3</volume>
<numero>3</numero>
<fpage>33</fpage>
<lpage>37</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_arttext&amp;pid=S2393-67972018000300033&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_abstract&amp;pid=S2393-67972018000300033&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_pdf&amp;pid=S2393-67972018000300033&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen: Se describe un caso de paraparesia espástica asociada al retrovirus HTLV-I, en una paciente de 34 años, cuyo diagnóstico se realizó 17 años después del inicio de su enfermedad. El mismo se obtuvo mediante la determinación de anticuerpos en sangre y líquido cefalorraquídeo. En la literatura nacional existen solo dos casos publicados previamente. El objetivo de la presentación del caso es recordar las principales características epidemiológicas, clínicas y paraclínicas de dicha patología, así como restablecer la importancia de considerar al HTLV-Ia la hora de búsqueda etiológica de una mielopatía crónica, y mantener los controles en sangre de donantes y hemoderivados para eliminar una de las principales vías de contagio.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract: A case of spastic paraparesis associated with HTLV-I retrovirus was described in a 34-year-old patient whose diagnosis was made 17 years after the onset of his disease. It was obtained by determining antibodies in blood and cerebrospinal fluid. In the national literature there are only two previously published cases. The objective of the presentation of the case is to recall the main epidemiological, clinical and paraclinical characteristics of said pathology, as well as to re-establish the importance of considering the HTLV-Ia the etiological search time of a chronic myelopathy, and to maintain the blood controls of donors and blood products to eliminate one of the main routes of infection.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo: Um caso de paraparesia espástica associado a retrovírus HTLV-I foi descrito em um paciente de 34 anos cujo diagnóstico foi feito 17 anos após o início da doença. Foi obtido pela determinação de anticorpos no sangue e no líquido cefalorraquidiano. Na literatura nacional existem apenas dois casos publicados anteriormente. O objetivo da apresentação do caso é relembrar as principais características epidemiológicas, clínicas e paraclínicas da referida patologia, bem como restabelecer a importância de considerar o HTLV-Ia o tempo de busca etiológica de uma mielopatia crônica e manter o controle sanguíneo dos doadores. e hemoderivados para eliminar uma das principais vias de infecção.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[paraparesia espástica]]></kwd>
<kwd lng="es"><![CDATA[HTLV-1]]></kwd>
<kwd lng="es"><![CDATA[patogenia]]></kwd>
<kwd lng="es"><![CDATA[epidemiología]]></kwd>
<kwd lng="es"><![CDATA[estudios confirmatorios]]></kwd>
<kwd lng="es"><![CDATA[control donantes]]></kwd>
<kwd lng="en"><![CDATA[spastic paraparesis]]></kwd>
<kwd lng="en"><![CDATA[HTLV-1]]></kwd>
<kwd lng="en"><![CDATA[pathogenesis]]></kwd>
<kwd lng="en"><![CDATA[epidemiology]]></kwd>
<kwd lng="en"><![CDATA[confirmatory studies]]></kwd>
<kwd lng="en"><![CDATA[donor control]]></kwd>
<kwd lng="pt"><![CDATA[paraparesia espástica]]></kwd>
<kwd lng="pt"><![CDATA[HTLV-1]]></kwd>
<kwd lng="pt"><![CDATA[patogênese]]></kwd>
<kwd lng="pt"><![CDATA[epidemiologia]]></kwd>
<kwd lng="pt"><![CDATA[estudos confirmatórios]]></kwd>
<kwd lng="pt"><![CDATA[controle de doadores]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gallo]]></surname>
<given-names><![CDATA[RC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The discovery of the first human retrovirus HTLV-1 and HTLV-2]]></article-title>
<source><![CDATA[Retrovirology]]></source>
<year>2005</year>
<volume>2</volume>
<page-range>17</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Goff]]></surname>
<given-names><![CDATA[SP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Retroviridae]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Knipe]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
<name>
<surname><![CDATA[Howley]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<source><![CDATA[Fields Virology]]></source>
<year>2013</year>
<edition>6ta</edition>
<publisher-loc><![CDATA[Philadelphia ]]></publisher-loc>
<publisher-name><![CDATA[Lippincott Williams &amp; Wilskins]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gessain]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Cassar]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiological aspects and world distribution of HTLV-I infection]]></article-title>
<source><![CDATA[Front Microbiol]]></source>
<year>2012</year>
<volume>3</volume>
<page-range>388</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Salamano]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Valiño]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[SavioE]]></surname>
</name>
<name>
<surname><![CDATA[Scaramelli]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Pietra]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Russi]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Paraparesia asociada al HTLV-1 Una nueva enfermedad en Uruguay: a propósito de dos casos clínicos]]></article-title>
<source><![CDATA[Rev Méd Urug]]></source>
<year>1998</year>
<volume>14</volume>
<page-range>69-72</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gessain]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Mahieux]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tropical spastic paraparesis and HTLV-I associated myelopathy Clinical, epidemiological, virological and therapeutic aspects]]></article-title>
<source><![CDATA[Rev Neurol (Paris)]]></source>
<year>2012</year>
<volume>168</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>257-69</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Casseb]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Is Human T Cell Lymphotropic Type 1 (HTLV-1)-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) Syndrome a Neglected Disease?]]></article-title>
<source><![CDATA[PLoS Negl Trop Dis]]></source>
<year>2009</year>
<volume>3</volume>
<numero>11</numero>
<issue>11</issue>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Muchinik]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Bouzas]]></surname>
<given-names><![CDATA[MB]]></given-names>
</name>
<name>
<surname><![CDATA[Zapiola]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Decaro]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Gallo]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[HTLV-I infection in Uruguay]]></article-title>
<source><![CDATA[J Acquir Immune Defic Syndr]]></source>
<year>1992</year>
<volume>5</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>743-4</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Balduini]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Priori]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Acosta]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Salazar]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Bianchi]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Infección por virus linfotrópico de células Thumanas (HTLV) en Uruguay identificación de problemas]]></article-title>
<source><![CDATA[An Facultad Med (Univ Repúb Urug)]]></source>
<year>2017</year>
<volume>4</volume>
<numero>Suppl 1</numero>
<issue>Suppl 1</issue>
<page-range>41-51</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ribas]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Melo]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy, Rev Soc Bras Med]]></article-title>
<source><![CDATA[Trop]]></source>
<year>2002</year>
<volume>35</volume>
<page-range>377-84</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="book">
<collab>Scientific Group on HTLV-I</collab>
<source><![CDATA[Infections and Associated Diseases, Kagoshima, Japan 10-15 December 1988: report]]></source>
<year>1989</year>
<publisher-loc><![CDATA[Manila ]]></publisher-loc>
<publisher-name><![CDATA[WHO]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rinni]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Lima]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<source><![CDATA[Valor Predictivo de las técnicas de tamizaje de enfermedades transmisibles, utilizadas en el Departamento de Hemoterapia del Hospital de Clínicas. Años 2001-2002. Monografía final postgrado Medicina Transfusional]]></source>
<year>2002</year>
<publisher-loc><![CDATA[Montevideo ]]></publisher-loc>
<publisher-name><![CDATA[Escuela de Graduados. UdelaR]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
